We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children.
- Authors
Dutta, Noton K.; Tornheim, Jeffrey A.; Fukutani, Kiyoshi F.; Paradkar, Mandar; Tiburcio, Rafael T.; Kinikar, Aarti; Valvi, Chhaya; Kulkarni, Vandana; Pradhan, Neeta; Shivakumar, Shri Vijay Bala Yogendra; Kagal, Anju; Gupte, Akshay; Gupte, Nikhil; Mave, Vidya; Gupta, Amita; Andrade, Bruno B.; Karakousis, Petros C.
- Abstract
Pediatric tuberculosis (TB) remains a major global health problem. Improved pediatric diagnostics using readily available biosources are urgently needed. We used liquid chromatography-mass spectrometry to analyze plasma metabolite profiles of Indian children with active TB (n = 16) and age- and sex-matched, Mycobacterium tuberculosis-exposed but uninfected household contacts (n = 32). Metabolomic data were integrated with whole blood transcriptomic data for each participant at diagnosis and throughout treatment for drug-susceptible TB. A decision tree algorithm identified 3 metabolites that correctly identified TB status at distinct times during treatment. N-acetylneuraminate achieved an area under the receiver operating characteristic curve (AUC) of 0.66 at diagnosis. Quinolinate achieved an AUC of 0.77 after 1 month of treatment, and pyridoxate achieved an AUC of 0.87 after successful treatment completion. A set of 4 metabolites (gamma-glutamylalanine, gamma-glutamylglycine, glutamine, and pyridoxate) identified treatment response with an AUC of 0.86. Pathway enrichment analyses of these metabolites and corresponding transcriptional data correlated N-acetylneuraminate with immunoregulatory interactions between lymphoid and non-lymphoid cells, and correlated pyridoxate with p53-regulated metabolic genes and mitochondrial translation. Our findings shed new light on metabolic dysregulation in children with TB and pave the way for new diagnostic and treatment response markers in pediatric TB.
- Subjects
INDIA; TUBERCULOSIS in children; MYCOBACTERIUM tuberculosis; WORLD health; METABOLITES; CHILDREN; LIQUID chromatography-mass spectrometry
- Publication
Scientific Reports, 2020, Vol 10, Issue 1, pN.PAG
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-020-75513-8